↓ Skip to main content

Cardiovascular Safety in Drug Development and Therapeutic Use

Overview of attention for book
Cardiovascular Safety in Drug Development and Therapeutic Use
Springer International Publishing

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 The Central Role of Cardiovascular Safety in Drug Development and Therapeutic Use
  3. Altmetric Badge
    Chapter 2 Drug Structures and the Biological Basis of Drug Responses
  4. Altmetric Badge
    Chapter 3 Cardiovascular Structure, Function, and Pathophysiology
  5. Altmetric Badge
    Chapter 4 Analyzing and Reporting Efficacy Data
  6. Altmetric Badge
    Chapter 5 Analyzing and Reporting Safety Data
  7. Altmetric Badge
    Chapter 6 Meta-analysis, Group Sequential Study Designs, Centralized Endpoint Adjudication, and Composite Endpoints
  8. Altmetric Badge
    Chapter 7 The Proarrhythmic Cardiac Safety Regulatory Landscape Circa 2005–2015: Drug-Induced hERG Channel Block and the Thorough QT/QTc Study
  9. Altmetric Badge
    Chapter 8 QTc Exposure–Response Modeling as a Primary Methodology for Proarrhythmic Cardiac Safety Assessments
  10. Altmetric Badge
    Chapter 9 The Comprehensive In Vitro Proarrhythmia Assay Initiative
  11. Altmetric Badge
    Chapter 10 Oncology Drug Therapy: Cardiotoxicity and the Discipline of Cardio-oncology
  12. Altmetric Badge
    Chapter 11 Blood Pressure Responses to Noncardiovascular Drugs in Development and Therapeutic Use
  13. Altmetric Badge
    Chapter 12 The Genesis of Cardiovascular Safety Regulatory Landscapes for New Antidiabetic Drugs for Type 2 Diabetes
  14. Altmetric Badge
    Chapter 13 Satisfying the Regulatory Requirements for New Antidiabetic Drugs for Type 2 Diabetes Most Expeditiously
  15. Altmetric Badge
    Chapter 14 Postmarketing Cardiovascular Safety Considerations
  16. Altmetric Badge
    Chapter 15 A Safety Perspective on Additional Aspects of Drug Development and Therapeutic Use
Overall attention for this book and its chapters
Altmetric Badge

Mentioned by

twitter
2 X users

Readers on

mendeley
101 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cardiovascular Safety in Drug Development and Therapeutic Use
Published by
Springer International Publishing, January 2017
DOI 10.1007/978-3-319-40347-2
ISBNs
978-3-31-940345-8, 978-3-31-940347-2
Authors

Turner, J. Rick, Karnad, Dilip R., Kothari, Snehal, J. Rick Turner, Dilip R. Karnad, Snehal Kothari

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Sweden 1 <1%
Unknown 100 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 12%
Student > Master 11 11%
Student > Ph. D. Student 11 11%
Other 5 5%
Researcher 5 5%
Other 14 14%
Unknown 43 43%
Readers by discipline Count As %
Nursing and Health Professions 19 19%
Medicine and Dentistry 12 12%
Biochemistry, Genetics and Molecular Biology 4 4%
Social Sciences 4 4%
Engineering 4 4%
Other 16 16%
Unknown 42 42%